Overview
- Legal name
- DNA SCRIPT INC
- Registered location
- CAMBRIDGE, MA, USA
- Website
- Company website ↗
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Nov 12, 2025
Read company summary
DNA SCRIPT INC is associated with UEI V5JNJ33ZCSM3 and CAGE 9HVG1 in public federal records. AcornBids currently links 2 prime awards totaling $686.5K in obligations to this entity. Its largest recorded federal customer by obligations is Department of Defense. Its recorded federal awards include work classified as Analytical Laboratory Instrument Manufacturing. These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists CAMBRIDGE, MA, USA.
At a glance
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Sep 28, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- DNA SCRIPT INC
- UEI
- V5JNJ33ZCSM3
- CAGE
- 9HVG1
- Registered address
- 185 ALEWIFE BROOK PKWY STE 210, CAMBRIDGE, MA, 02138, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Jul 16, 2026
- Initial registration
- Mar 15, 2023
- Entity start
- Jul 16, 2018
- SAM updated
- Jul 16, 2026
- Registration expires
- Jun 30, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Federal award analysis
Net transaction obligations by federal fiscal period.
Transaction history is not available in the loaded data. Annual funding is not estimated from current award totals.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| HT942524P0014DEOXYRIBONUCLEIC ACID SYNTHESIZER | Department of Defense | $344.5K | Nov 22, 2023 | Dec 14, 2028 |
| 75N93024P01215THE PURCHASE OF THIS ACQUISITION IS TO PURCHASE ONE (1) SYNTAX SYSTEM MODEL 200 INSTRUMENT MODEL STX-200 | Department of Health and Human Services | $342.0K | Sep 26, 2024 | Sep 25, 2025 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jul 16, 2026 |
| Source loaded | Sep 19, 2026 |
| Initial registration | Mar 15, 2023 |
| Entity start | Jul 16, 2018 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| IBRAHIM DRIBINE | Government business | Contact method not published | SAM registration | Not available |
| IBRAHIM DRIBINE | Electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
No official subaward rows are loaded, so Acorn does not claim known teaming relationships.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit